1. Edge, S.B., et al., AJCC 7th Ed Cancer Staging Manual 7th. 2015: Springer New York Dordrecht Heidelberg London.
2. China, N.H.C.o.t.P.s.R.o., Chinese Protocol of diagnosis and treatment of colorectal cancer (2020 edition). 2020: People`s Medical Publishing House.
3. Zak, Y., H.G. Moore, and B.C. Ghosh, Patterns of Recurrence of Colorectal Cancer. Journal of Surgical Oncology, 2008. 97: p. 1-2.
4. Katoh, M., et al., Bone metastasis from colorectal cancer in autopsy cases. Journal of Gastroenterology, 1995. 30: p. 615–618.
5. Poston, G.J., et al., Diagnosis and management of colorectal cancer: summary of NICE guidance. BMJ, 2011. 343: p. d6751.
6. Lee, C.H., et al., Vimentin as a potential molecular target in cancer therapy Or Vimentin, an overview and its potential as a molecular target for cancer therapy. BioFactors, 2007. 29: p. 19–35.
7. Zlobec, I. and A. Lugli, Tumour budding in colorectal cancer: molecular rationale for clinical translation. Nat Rev Cancer, 2018 18(4): p. 203-204.
8. Aasebo, K., et al., CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup. Front Oncol, 2020. 10: p. 8.
9. Sisik, A., et al., CEA and CA 19-9 are still valuable markers for the prognosis of colorectal and gastric cancer patients. Asian Pac J Cancer Prev, 2013. 14(7): p. 4289-94.
10. Hutchinson, L., Gastrointestinal cancer: CDX2: prognostic marker for high-risk colon cancer. Nat Rev Clin Oncol, 2016. 13(3): p. 134-5.
11. Smedt, L.D., et al., Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching. Br J Cancer, 2017. 116(1): p. 58-65.
12. Elkouby, Y.M., et al., Mesodermal Wnt signaling organizes the neural plate via Meis3. Development, 2010. 137(9): p. 1531-41.
13. Sonnet, W., R. Rezsohazy, and I. Donnay, Characterization of TALE genes expression during the first lineage segregation in mammalian embryos. Dev Dyn, 2012. 241(11): p. 1827-39.
14. Liu, J., et al., Three-amino-acid-loop-extension homeodomain factor Meis3 regulates cell survival via PDK1. Proc Natl Acad Sci USA, 2010. 107(47): p. 20494-9.
15. Staffas, A., et al., Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice. Oncogene, 2017. 36(11): p. 1516-1524.
16. Li, Z., et al., PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease. Cancer Res, 2016. 76(3): p. 619-29.
17. Pillay, L.M., et al., The Hox cofactors Meis1 and Pbx act upstream of gata1 to regulate primitive hematopoiesis. Dev Biol, 2010. 340(2): p. 306-17.
18. Machon1, O., et al., Meis2 is essential for cranial and cardiac neural crest development. BMC Developmental Biology, 2015. 15: p. 40.
19. Vegi, N.M., et al., MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML. Cell Reports, 2016. 16: p. 498–507.
20. Castillo, A., et al., 19q13.32 microdeletion syndrome: three new cases. Eur J Med Genet, 2014. 57(11-12): p. 654-8.
21. Vlachakis, N., S.K. Choe, and C.G. Sagerstrom, Meis3 synergizes with Pbx4 and Hoxb1b in promoting hindbrain fates in the zebrafish. Development, 2001. 128(8): p. 1299-312.
22. Uribe, R.A. and M.E. Bronner, Meis3 is required for neural crest invasion of the gut during zebrafish enteric nervous system development. Mol Biol Cell, 2015. 26(21): p. 3728-40.
23. Green, M.R. and J. Sambrook, Molecular Cloning:A Laboratory Manual. 2012.
24. Tang, Z., et al., GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Research, 2017. 45(1): p. W98–W102.
25. Kassambara, A., et al., GenomicScape: An Easy-to-Use Web Tool for Gene Expression Data Analysis. Application to Investigate the Molecular Events in the Differentiation of B Cells into Plasma Cells. PLOS Computational Biology, 2015.
26. Cheah, P.Y., et al., A survival-stratification model of human colorectal carcinomas with beta-catenin and p27kip1. Cancer, 2002. 95(12): p. 2479-2486.
27. Gao, Z.-H., et al., Differential β-catenin expression levels are associated with morphological features and prognosis of colorectal cancer. Oncol Lett, 2014 8(5): p. 2069-2076.
28. Chen, Q., et al., MiR-124-5p inhibits the growth of high-grade gliomas through posttranscriptional regulation of LAMB1. Neuro Oncol, 2014. 16(5): p. 637-51.
29. Govaere, O., et al., The PDGFRalpha-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma. Oncogene, 2017. 36(47): p. 6605-6616.
30. Ngan, C.Y., et al., Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer. British Journal of Cancer, 2007. 96: p. 986–992.
31. Gavert, N. and A. Ben-Ze'ev, Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol Med, 2008 14(5): p. 199-209.
32. Hong, Y., et al., A Susceptibility Gene Set for Early Onset Colorectal Cancer That Integrates Diverse Signaling Pathways: Implication for Tumorigenesis. Clin Cancer Res, 2007. 13(4): p. 1107-1114.
33. Dibner, C., et al., The Meis3 protein and retinoid signaling interact to pattern the Xenopus hindbrain. Dev Biol, 2004. 271(1): p. 75-86.
34. S. Steeg, P., Targeting metastasis. Nature Reviews Cancer, 2016. 16: p. 201–218.
35. Nasif, W.A., et al., Implications of CEA and p53 overexpression in the poor prognosis of colorectal cancer. Med Oncol, 2006. 23(2): p. 237-44.
36. Li, Y., et al., Combining Red Blood Cell Distribution Width (RDW-CV) and CEA Predict Poor Prognosis for Survival Outcomes in Colorectal Cancer. Journal of Cancer, 2019. 10(5): p. 1162-1170.
37. Elkouby, Y.M., et al., A hindbrain-repressive Wnt3a/Meis3/Tsh1 circuit promotes neuronal differentiation and coordinates tissue maturation. Development, 2012. 139(8): p. 1487-97.
38. Horejs, C.M., et al., Biologically-active laminin-111 fragment that modulates the epithelial-to-mesenchymal transition in embryonic stem cells. Proc Natl Acad Sci USA, 2014. 111(16): p. 5908-5913.